ÂÜÀòÂÒÂ×

Daniel Hart, Ph.D., is head of technology development at Epic Bio. Dr. Hart completed postdoctoral training in the laboratory of Michael R. Green at the University of Massachusetts. Previously, he was an assistant professor in the Cardiovascular Research Institute at University of California, San Francisco. Dr. Hart’s laboratory used genome engineering approaches, including CRISPR and CRISPRa/i, to study gene regulatory networks in vertebrate cardiovascular development.

Dr. Hart received his B.Sc. in biochemistry from the University of Manchester, his M.Sc. in biotechnology from the University of Abertay Dundee, and his Ph.D. in molecular biology from the University of Manchester in the United Kingdom.